Global Angiotensin Receptor Antagonists Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Angiotensin Receptor Antagonists

• 1.1 Definition of Angiotensin Receptor Antagonists
• 1.2 Angiotensin Receptor Antagonists Segment by Type
  • 1.2.1 Global Angiotensin Receptor Antagonists Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Valsartan
  • 1.2.3 Telmisartan
  • 1.2.4 Losartan
  • 1.2.5 Irbesartan
  • 1.2.6 Azilsartan
  • 1.2.7 Olmesartan
• 1.3 Angiotensin Receptor Antagonists Segment by Applications
  • 1.3.1 Global Angiotensin Receptor Antagonists Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hypertension
  • 1.3.3 Cardiovascular Diseases
  • 1.3.4 Kidney Diseases
  • 1.3.5 Other
• 1.4 Global Angiotensin Receptor Antagonists Overall Market
  • 1.4.1 Global Angiotensin Receptor Antagonists Revenue (2014-2025)
  • 1.4.2 Global Angiotensin Receptor Antagonists Production (2014-2025)
  • 1.4.3 North America Angiotensin Receptor Antagonists Status and Prospect (2014-2025)
  • 1.4.4 Europe Angiotensin Receptor Antagonists Status and Prospect (2014-2025)
  • 1.4.5 China Angiotensin Receptor Antagonists Status and Prospect (2014-2025)
  • 1.4.6 Japan Angiotensin Receptor Antagonists Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Angiotensin Receptor Antagonists Status and Prospect (2014-2025)
  • 1.4.8 India Angiotensin Receptor Antagonists Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Angiotensin Receptor Antagonists
• 2.3 Manufacturing Process Analysis of Angiotensin Receptor Antagonists
• 2.4 Industry Chain Structure of Angiotensin Receptor Antagonists

3 Development and Manufacturing Plants Analysis of Angiotensin Receptor Antagonists

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Angiotensin Receptor Antagonists Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Angiotensin Receptor Antagonists
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Angiotensin Receptor Antagonists Production and Capacity Analysis
• 4.2 Angiotensin Receptor Antagonists Revenue Analysis
• 4.3 Angiotensin Receptor Antagonists Price Analysis
• 4.4 Market Concentration Degree

5 Angiotensin Receptor Antagonists Regional Market Analysis

• 5.1 Angiotensin Receptor Antagonists Production by Regions
  • 5.1.1 Global Angiotensin Receptor Antagonists Production by Regions
  • 5.1.2 Global Angiotensin Receptor Antagonists Revenue by Regions
• 5.2 Angiotensin Receptor Antagonists Consumption by Regions
• 5.3 North America Angiotensin Receptor Antagonists Market Analysis
  • 5.3.1 North America Angiotensin Receptor Antagonists Production
  • 5.3.2 North America Angiotensin Receptor Antagonists Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Angiotensin Receptor Antagonists Import and Export
• 5.4 Europe Angiotensin Receptor Antagonists Market Analysis
  • 5.4.1 Europe Angiotensin Receptor Antagonists Production
  • 5.4.2 Europe Angiotensin Receptor Antagonists Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Angiotensin Receptor Antagonists Import and Export
• 5.5 China Angiotensin Receptor Antagonists Market Analysis
  • 5.5.1 China Angiotensin Receptor Antagonists Production
  • 5.5.2 China Angiotensin Receptor Antagonists Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Angiotensin Receptor Antagonists Import and Export
• 5.6 Japan Angiotensin Receptor Antagonists Market Analysis
  • 5.6.1 Japan Angiotensin Receptor Antagonists Production
  • 5.6.2 Japan Angiotensin Receptor Antagonists Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Angiotensin Receptor Antagonists Import and Export
• 5.7 Southeast Asia Angiotensin Receptor Antagonists Market Analysis
  • 5.7.1 Southeast Asia Angiotensin Receptor Antagonists Production
  • 5.7.2 Southeast Asia Angiotensin Receptor Antagonists Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Angiotensin Receptor Antagonists Import and Export
• 5.8 India Angiotensin Receptor Antagonists Market Analysis
  • 5.8.1 India Angiotensin Receptor Antagonists Production
  • 5.8.2 India Angiotensin Receptor Antagonists Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Angiotensin Receptor Antagonists Import and Export

6 Angiotensin Receptor Antagonists Segment Market Analysis (by Type)

• 6.1 Global Angiotensin Receptor Antagonists Production by Type
• 6.2 Global Angiotensin Receptor Antagonists Revenue by Type
• 6.3 Angiotensin Receptor Antagonists Price by Type

7 Angiotensin Receptor Antagonists Segment Market Analysis (by Application)

• 7.1 Global Angiotensin Receptor Antagonists Consumption by Application
• 7.2 Global Angiotensin Receptor Antagonists Consumption Market Share by Application (2014-2019)

8 Angiotensin Receptor Antagonists Major Manufacturers Analysis

• 8.1 Pfizer
  • 8.1.1 Pfizer Angiotensin Receptor Antagonists Production Sites and Area Served
  • 8.1.2 Pfizer Product Introduction, Application and Specification
  • 8.1.3 Pfizer Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Novartis
  • 8.2.1 Novartis Angiotensin Receptor Antagonists Production Sites and Area Served
  • 8.2.2 Novartis Product Introduction, Application and Specification
  • 8.2.3 Novartis Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Merck
  • 8.3.1 Merck Angiotensin Receptor Antagonists Production Sites and Area Served
  • 8.3.2 Merck Product Introduction, Application and Specification
  • 8.3.3 Merck Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Astra Zeneca
  • 8.4.1 Astra Zeneca Angiotensin Receptor Antagonists Production Sites and Area Served
  • 8.4.2 Astra Zeneca Product Introduction, Application and Specification
  • 8.4.3 Astra Zeneca Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Jhonson and Johnson
  • 8.5.1 Jhonson and Johnson Angiotensin Receptor Antagonists Production Sites and Area Served
  • 8.5.2 Jhonson and Johnson Product Introduction, Application and Specification
  • 8.5.3 Jhonson and Johnson Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Eli Lilly
  • 8.6.1 Eli Lilly Angiotensin Receptor Antagonists Production Sites and Area Served
  • 8.6.2 Eli Lilly Product Introduction, Application and Specification
  • 8.6.3 Eli Lilly Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Sanofi
  • 8.7.1 Sanofi Angiotensin Receptor Antagonists Production Sites and Area Served
  • 8.7.2 Sanofi Product Introduction, Application and Specification
  • 8.7.3 Sanofi Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Bristol-Myers Squibb
  • 8.8.1 Bristol-Myers Squibb Angiotensin Receptor Antagonists Production Sites and Area Served
  • 8.8.2 Bristol-Myers Squibb Product Introduction, Application and Specification
  • 8.8.3 Bristol-Myers Squibb Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Bayer
  • 8.9.1 Bayer Angiotensin Receptor Antagonists Production Sites and Area Served
  • 8.9.2 Bayer Product Introduction, Application and Specification
  • 8.9.3 Bayer Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 GSK
  • 8.10.1 GSK Angiotensin Receptor Antagonists Production Sites and Area Served
  • 8.10.2 GSK Product Introduction, Application and Specification
  • 8.10.3 GSK Angiotensin Receptor Antagonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Teva Pharmaceutical

9 Development Trend of Analysis of Angiotensin Receptor Antagonists Market

• 9.1 Global Angiotensin Receptor Antagonists Market Trend Analysis
  • 9.1.1 Global Angiotensin Receptor Antagonists Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Angiotensin Receptor Antagonists Regional Market Trend
  • 9.2.1 North America Angiotensin Receptor Antagonists Forecast 2019-2025
  • 9.2.2 Europe Angiotensin Receptor Antagonists Forecast 2019-2025
  • 9.2.3 China Angiotensin Receptor Antagonists Forecast 2019-2025
  • 9.2.4 Japan Angiotensin Receptor Antagonists Forecast 2019-2025
  • 9.2.5 Southeast Asia Angiotensin Receptor Antagonists Forecast 2019-2025
  • 9.2.6 India Angiotensin Receptor Antagonists Forecast 2019-2025
• 9.3 Angiotensin Receptor Antagonists Market Trend (Product Type)
• 9.4 Angiotensin Receptor Antagonists Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Angiotensin Receptor Antagonists Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List